[Risk stratification using combined ECG, clinical, and biochemical assessment in patients with chest pain without ST-segment elevation. How long should we wait? ].

@article{Portales2003RiskSU,
  title={[Risk stratification using combined ECG, clinical, and biochemical assessment in patients with chest pain without ST-segment elevation. How long should we wait? ].},
  author={Javier Fern{\'a}ndez Portales and Fabiola P{\'e}rez Reyes and Jose Antonio Garc{\'i}a Robles and Javier Jim{\'e}nez Candil and Esther P{\'e}rez David and Juan R Rey Blas and Leopoldo P{\'e}rez de Isla and Oscar D{\'i}az Castro and J. Almendral},
  journal={Revista espanola de cardiologia},
  year={2003},
  volume={56 4},
  pages={338-45}
}
INTRODUCTION We use clinical, ECG, and biochemical data to stratify risk in patients with chest pain without ST segment elevation. However, the prognostic performance of these studies in relation to time from onset of symptoms is unknown. PATIENTS AND METHOD In a single-center, prospective study, 321 consecutive patients who had been admitted in the emergency room with a suspected acute coronary syndrome without ST segment elevation were included in the study. Blood samples were collected for… CONTINUE READING